RDHL RedHill Biopharma Ltd.

NASDAQ
$0.63

RedHill Biopharma Ltd. (RDHL) is expected to report earnings on April 27, 2026, before the market open.

Earnings Date
Apr 27
Monday · 8:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About RedHill Biopharma Ltd.

Redhill Biopharma Ltd is a biopharmaceutical company. It develops & acquires late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers.

Sector

Healthcare